← Back
Data updated: Mar 10, 2026
POHL BOSKAMP
Cardiovascular
POHL BOSKAMP is a specialty pharmaceutical company focused on Cardiovascular. Key products include GONITRO.
1985
Since
5
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (4)
Company Info
- First Approval
- 1985-10-31
- Latest
- 2018-07-30
- Applications
- 3